Gary S. Stetz sold $344k of CNTN
director at Tharimmune, Inc.. 100,351 shares at an average of $3.43, traded May 22, 2026, filed May 27, 2026.
Score components
- +15RoleDirector
- +15Trade size$344k at market
- +10Share of holdings soldSold 43% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-26-025469, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 22, 2026 | SOpen-market sale Common Stock | -10,000 | $3.45 | $35k | 224,526 | May 27, 2026 |
| May 22, 2026 | SOpen-market sale Common Stock | -10,000 | $3.45 | $35k | 214,526 | May 27, 2026 |
| May 22, 2026 | SOpen-market sale Common Stock | -15,000 | $3.40 | $51k | 199,526 | May 27, 2026 |
| May 22, 2026 | SOpen-market sale Common Stock | -15,000 | $3.41 | $51k | 184,526 | May 27, 2026 |
| May 22, 2026 | SOpen-market sale Common Stock | -15,000 | $3.41 | $51k | 169,526 | May 27, 2026 |
| May 22, 2026 | SOpen-market sale Common Stock | -10,000 | $3.40 | $34k | 159,526 | May 27, 2026 |
| May 22, 2026 | SOpen-market sale Common Stock | -12,851 | $3.44 | $44k | 146,675 | May 27, 2026 |
| May 26, 2026 | SOpen-market sale Common Stock | -12,500 | $3.47 | $43k | 134,175 | May 27, 2026 |
Related signals
Other insiders at Tharimmune, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 67Notable | Tharimmune, Inc. | Sireesh Appajosyula Chief Executive Officer | $91k 61,496 shares | +1824% | |
| 71Notable | Tharimmune, Inc. | Gravitas Capital LP Executive Chairman | $500k 337,838 shares | +86% | |
| 53Moderate | Tharimmune, Inc. | Sanam Parikh COO | $1,450 1,000 shares | +130% | |
| 31Weak | CNTNbuy Tharimmune, Inc. | Sanam Parikh COO | $1,001 770 shares | - | |
| 31Weak | CNTNbuy Tharimmune, Inc. | Randy Milby CEO | $9,752 4,600 shares | +36% | |
| 30Weak | CNTNbuy Tharimmune, Inc. | Sireesh Appajosyula Chief Operating Officer | $10k 5,000 shares | +87% | |
| 44Moderate | CNTNbuy Tharimmune, Inc. | Randy Milby CEO | $15k 29,000 shares | +23% | |
| 46Moderate | CNTNbuy Tharimmune, Inc. | Randy Milby CEO | $10k 10,000 shares | +9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.